CHI3L1 and Parkinson disease: Patients with AD exhibited mean CSF YKL-40 concentrations that were 21.3%, 27.7% and 38.8% higher than those of non-demented controls (p = 0.0283), DLB (p = 0.0027) and PD patients (p<0.0001) respectively (Fig 1B).